Dr Debra Barker appointed interim CEO of Destiny Pharma as Neil Clark steps down May 25, 2023 BRIGHTON, UNITED KINGDOM: Destiny Pharma plc (AIM: DEST), a clinical stage innovative biotechnology company focused on the development of novel medicines that can prevent…